Zika Virus Threat Puts Abortion Rights And Disability Rights On Collision Course
By Chloe Angyal,
HuffPost Politics
| 02. 04. 2016
Untitled Document
As more cases of Zika virus pop up in the U.S., abortion rights advocates are raising concerns about whether harsh abortion restrictions will affect pregnant women’s ability to terminate pregnancies if they’re infected with the virus.
Zika has been linked to microcephaly, in which babies are born with underdeveloped brains and abnormally small heads. Some cases seen in Brazil and elsewhere in the Americas have been severe. As The Huffington Post reported last week, people born with microcephaly “may suffer from additional ailments, including convulsions, impaired vision and hearing, deformed limbs and severe breathing problems.”
In El Salvador, where abortion is completely outlawed, the government has advised women to simply not get pregnant until 2018. In Brazil and other Latin American countries, the outbreak has officials re-examining strict abortion laws. Here in the U.S., officials have stayed mum on the topic, but abortion rights advocates are rightly wondering what an increase in fetal abnormalities would mean at a time where abortion restrictions -- from lengthy waiting periods to laws designed to shutter clinics -- have left...
Related Articles
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...